Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.

Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. · 2020

Read Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. by Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7100515.txt.

Description

Ou and co-authors characterised the spike glycoprotein of SARS-CoV-2 and its cross-reaction with the earlier SARS virus, in Nature Communications. Using a pseudovirus system built on the spike protein, they tested how the new virus enters cells. Little was known about the virus's biology at the time.

Human ACE2 was confirmed as the entry receptor, and the virus entered mainly by endocytosis, the cell's swallowing route. Three cell factors proved critical for entry, and the new spike was less stable than the SARS one. Antibodies against SARS spike blocked SARS but not the new virus. Blood from recovered patients showed limited cross-neutralisation, so one infection might not protect against the other.

Catalog record

CREATOROu X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7100515

Browse the full library · About the Tower of Babel